[go: up one dir, main page]

SE8005824L - Vaccin av hudparvovirus samt forfarande for dess framstellning - Google Patents

Vaccin av hudparvovirus samt forfarande for dess framstellning

Info

Publication number
SE8005824L
SE8005824L SE8005824A SE8005824A SE8005824L SE 8005824 L SE8005824 L SE 8005824L SE 8005824 A SE8005824 A SE 8005824A SE 8005824 A SE8005824 A SE 8005824A SE 8005824 L SE8005824 L SE 8005824L
Authority
SE
Sweden
Prior art keywords
vaccin
skin
procedure
preparation
canine
Prior art date
Application number
SE8005824A
Other languages
English (en)
Other versions
SE423312B (sv
Inventor
M J G Appel
L E Carmichael
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of SE8005824L publication Critical patent/SE8005824L/sv
Publication of SE423312B publication Critical patent/SE423312B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/818Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8005824A 1978-12-20 1980-08-19 Vaccin av hundparvovirus och sett for dess framstellnig SE423312B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/971,296 US4193991A (en) 1978-12-20 1978-12-20 Canine parvovirus vaccine

Publications (2)

Publication Number Publication Date
SE8005824L true SE8005824L (sv) 1980-08-19
SE423312B SE423312B (sv) 1982-05-03

Family

ID=25518175

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8005824A SE423312B (sv) 1978-12-20 1980-08-19 Vaccin av hundparvovirus och sett for dess framstellnig

Country Status (11)

Country Link
US (1) US4193991A (sv)
EP (1) EP0020743A1 (sv)
JP (1) JPS6330287B2 (sv)
AU (1) AU532290B2 (sv)
CA (1) CA1138772A (sv)
DE (1) DE2953417C2 (sv)
GB (1) GB2048071B (sv)
NL (1) NL7920193A (sv)
NZ (1) NZ192477A (sv)
SE (1) SE423312B (sv)
WO (1) WO1980001243A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
JPS58408B2 (ja) * 1980-09-04 1983-01-06 株式会社 微生物化学研究所 イヌパルボウイルス感染症不活化ワクチン
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
AU633349B2 (en) * 1989-08-08 1993-01-28 Fort Dodge Australia Pty Limited Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
ATE129284T1 (de) * 1989-08-08 1995-11-15 Webster Arthur Pty Ltd Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US20060094105A1 (en) 1998-04-24 2006-05-04 University Hospitals Of Cleveland Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses
US6946291B2 (en) * 1998-04-24 2005-09-20 University Hospitals Of Cleveland Mixed cell diagnostic systems
US6168915B1 (en) * 1998-04-24 2001-01-02 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
CA2510189A1 (en) * 2002-12-19 2004-07-08 Thomas Gore Trivalent vaccine with maternal antibody transfer via the milk
RU2242994C1 (ru) * 2003-08-05 2004-12-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Штамм № r-72 вниизж парвовируса собак для изготовления диагностических и вакцинных препаратов
SI2578229T1 (sl) 2004-09-09 2013-10-30 Novartis Vaccines And Diagnostics Gmbh Zmanjšanje potencialnih iatrogenih tveganj, povezanih z antigeni cepiv
US7435588B2 (en) * 2005-09-20 2008-10-14 Diagnostic Hybrids, Inc. Systems for detection and production of respiratory, herpes and enteric viruses
SG182206A1 (en) * 2007-06-14 2012-07-30 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
JP2012519471A (ja) * 2009-01-30 2012-08-30 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ 北米のイヌにおいて広まっているイヌジステンパーウイルスに基づく免疫原性組成物、ワクチンおよび診断法
RU2565538C2 (ru) 2009-10-14 2015-10-20 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Выделение вируса, родственного парвовирусу-2 собак, от енота
CN104324272A (zh) * 2014-11-23 2015-02-04 烟台海研制药有限公司 治疗犬细小病毒病的中药组合物
EP4107168A1 (en) 2020-02-21 2022-12-28 Intervet International B.V. Novel erythroparvovirus associated with respiratory distress in equine

Also Published As

Publication number Publication date
US4193991A (en) 1980-03-18
JPS6330287B2 (sv) 1988-06-17
WO1980001243A1 (en) 1980-06-26
SE423312B (sv) 1982-05-03
NL7920193A (nl) 1980-10-31
EP0020743A1 (en) 1981-01-07
JPS55501177A (sv) 1980-12-25
GB2048071A (en) 1980-12-10
DE2953417C2 (de) 1987-08-20
CA1138772A (en) 1983-01-04
AU532290B2 (en) 1983-09-22
GB2048071B (en) 1983-09-21
NZ192477A (en) 1983-02-15
AU5405679A (en) 1980-06-26
DE2953417T1 (sv) 1981-01-29

Similar Documents

Publication Publication Date Title
SE8005824L (sv) Vaccin av hudparvovirus samt forfarande for dess framstellning
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
ATE104698T1 (de) Influenza-impfstoff.
JPS5527178A (en) Live influenza virus vaccine
DK16087A (da) Mastitis-vaccine
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
JPS5696692A (en) Novel influenza virus strain and influenza virus vaccine containing same
GB928807A (en) Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture
DE2966648D1 (en) Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
Cox Living modified viruses as immunizing agents
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
RO76563A2 (ro) Procedeu de stabilizare a unui vaccin antiherpetic
SE9503309D0 (sv) Method to identify therapeutically active compounds
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
ATE62134T1 (de) Biologische zubereitungen.
Haffer Field test studies of the 2512 strain of infectious bursal disease
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
SU143200A1 (ru) Способ изготовлени сухой вирус-вакцины против псевдочумы птиц
ES266270A1 (es) Procedimiento para preparar vacunas poliomieliticas
ES437787A1 (es) Un procedimiento para la preparacion de un virus vivo ate- nuado de varicela.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8005824-1

Effective date: 19940710

Format of ref document f/p: F